Steven Kaster
Family Medicine · Wenatchee, WANPI 1467478792
Payments from drug & device makers
Across 531 payments — averaging $7580.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3.2M
- Novo Nordisk AS$412K
- Eli Lilly$298K
- GSK$102K
- Merck$5K
- Novartis$655
- plus $14 from 1 others
Across 5 payments — averaging $2759.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$14K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 240 | $3,208,232 |
| Novo Nordisk AS | 245 | $412,335 |
| Eli Lilly | 12 | $297,738 |
| GSK | 30 | $101,556 |
| Merck | 2 | $4,800 |
| Novartis | 1 | $655 |
| AstraZeneca | 1 | $14 |
How this compares
$4,025,330 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Wenatchee
- Anton GraschWenatchee$5.3M
- Kathryn ErenWenatchee$112K
- Andrew TothWenatchee$25K
- Gaylon KippBellevue$4.8M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
- Kevin HatfieldSeattle$527K
- Steven SmithAuburn$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.